Happy Clinical Trials Day: Reflections from the Stanford Cancer Institute’s Cancer Clinical Trials Office
Image: Sarah Pelta
Stanford Cancer Institute
Translating Stanford discoveries into individualized cancer care
Immunotherapy and cell therapy expand treatment possibilities for melanoma patients
To learn more about current melanoma treatment and advances in treatment, we talked with SCI member Allison Betof Warner, MD, PhD, leader of Stanford’s Melanoma & Cutaneous Oncology Clinical Research Group.
Wipe Out Melanoma: Changing the way our community faces melanoma
The program aims to provide susceptible communities with the proper melanoma resources and education to catch the disease in its early stages when it is much more treatable.
Patel Named Advocacy Champion by the Association for Clinical Oncology (ASCO)
ASCO recognized SCI member Manali Patel as an Advocacy Champion due to her efforts in ensuring equitable, high-quality cancer care for all.
The Future of Cancer
The SCI is focused on pushing the limits of what we can do and what we know. The only way to really advance our knowledge is to push forward in laboratories, keep thinking about novel approaches, novel mechanisms. We cannot stand still!
National Cancer Institute Designation
The Stanford Cancer Institute has been designated a Comprehensive Cancer Center by the National Cancer Institute, a part of the National Institutes of Health and the world’s leading cancer research organization.
Designation as a Comprehensive Cancer Center signifies that the Stanford Cancer Institute maintains the highest level of scientific rigor, institutional support and coordination for the complete range of cancer-related research, including basic, translational, clinical and population-based science. The designation is recognition of the institute’s robust and integrated programs encompassing laboratory research, clinical care and community outreach and education.
The Institute’s mission is to support and coordinate the wide range of cancer-related activities — in basic, translational, clinical and population-based science — occurring at Stanford University, Stanford Health Care and Lucile Packard Children’s Hospital Stanford. Its over 450 members include scientists and physicians from a wide range of disciplines, all collaborating to translate research advances into improved cancer treatments.
-
Genes linked to familial brain cancer identified in Stanford Medicine-led study
An international effort led by a Stanford Medicine researcher finds more than 50 genes linked to glioma — a rare brain cancer. Although most gliomas are sporadic, a minority are inherited.
-
Video distraction helps kids undergo cancer radiotherapy, Stanford Medicine-led study finds
Most children receiving radiation therapy for cancer can hold still without anesthesia if they watch videos during the treatment, a study of a technique developed at Stanford Medicine found.
-
Antibiotics after breast cancer linked to poorer survival, Stanford Medicine-led study finds
Triple-negative breast cancer patients who used antibiotics within three years of diagnosis have an increased risk of death, according to a study. The gut microbiome is a likely link.
-
Researchers use skin-colonizing bacteria to create a topical cancer therapy in mice
In a study led by Stanford Medicine, researchers harnessed the skin’s immune response to bacteria to create an immunotherapy — delivered by swab — that treats aggressive tumors in mice.
Cancer Clinical Trials
Stanford Cancer Institute offers leading edge research and compassionate care with over 250 actively recruiting clinical trials, investigating a broad spectrum of new diagnostic, prevention and treatment strategies.